You should not take APRISO extended-release capsules if you experience an allergic reaction to IMPORTANT SAFETY INFORMATION-APRISO extended-release capsules
Please click here for full Prescribing Information for APRISO extended-release capsules. Please see below for complete Important Safety Information. Talk to your doctor if you have any kidney problems before taking APRISO. It is recommended that you have an evaluation of kidney function prior to treatment with APRISO therapy and periodically while on therapy. Kidney impairment has been reported in patients given products like APRISO (contain mesalamine or are converted to mesalamine). You should not take APRISO extended-release capsules if you experience an allergic reaction to salicylates or aminosalicylates, or to any of the components of APRISO capsules. The safety and efficacy of APRISO for treating UC beyond 6 months has not been evaluated in controlled clinical trials.
This special technology is designed to reach the colon and work right at the source of UC symptoms and "flare-ups." APRISO can be taken with or without food.ĪPRISO capsules are made with a special INTELLICOR technology, which allows the medication to be released slowly in your body over time. Once-daily APRISO maintained UC remission for up to 6 months in a majority of patientsįour APRISO capsules (1.5 g total) were taken once a day in the morning and helped patients 18 years of age or older with UC stay symptom free for up to 6 months. Discover an ulcerative colitis (UC) therapy that may help keep your UC in remission In clinical trials,